<DOC>
	<DOCNO>NCT01773993</DOCNO>
	<brief_summary>To collect efficacy safety information Pregabalin Fibromyalgia patient related appropriate use daily practice .</brief_summary>
	<brief_title>Special Investigation Pregabalin Fibromyalgia ( Regulatory Post Marketing Commitment Plan )</brief_title>
	<detailed_description>All patient investigator prescribes first pregabalin register consecutively number subject reach target number order extract patient enrol investigation random .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Clinical diagnosis Fibromyalgia Pregabalin naive patient Clinical diagnosis neuropathic pain</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Lyrica</keyword>
	<keyword>pregabalin</keyword>
	<keyword>Good post marketing practice</keyword>
	<keyword>Post Marketing Surveillance</keyword>
	<keyword>Regulatory Post Marketing Commitment Plan</keyword>
	<keyword>Fibromyalgia</keyword>
</DOC>